News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Salix Pharmaceuticals, Ltd. (SLXP) Completes Merger With InKine Pharmaceutical Company, Inc. (INKP)


10/19/2005 5:13:17 PM

RALEIGH, N.C.--(BUSINESS WIRE)--Oct. 3, 2005--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced that the merger of Salix Pharmaceuticals, Ltd. and InKine Pharmaceutical Company, Inc. has been completed. InKine stockholders received approximately 9 million newly issued shares of Salix common stock for InKine shares owned based on an exchange ratio of 0.1737 of a share of Salix common stock for each share of InKine common stock.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES